ArticleFrontiers in oncology2022

The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis.

Marko Roblek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.